Brief: Austar Lifesciences Announces FY Loss Attributable From Continuing Ops Of RMB32.6 Mln
26/03/2024 15:26
March 26 (Reuters) - Austar Lifesciences Ltd 6118.HK :
* FY LOSS ATTRIBUTABLE FROM CONTINUING OPERATIONS RMB32.6
MILLION
VERSUS PROFIT RMB104.2 MILLION
Further company coverage: 6118.HK
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Austar Lifesciences
See all newsAustar Lifesciences H1 profit drops on higher R&D spending
Brief: Austar Lifesciences Expects HY Profit Attributable Of RMB8 Million-RMB10 Million
Brief: Austar Lifesciences Posts FY Revenue RMB 1,530.7 Million
Brief: Austar Lifesciences Expects Profit Attributable Of Not Less Than RMB30 Million For FY
Brief: Austar Lifesciences Says Chen Yuewu Resigned As Executive Director